For over four decades, YMC has striven to provide solutions to biopharmaceutical and pharmaceutical companies that utilize purification processes in the development of drug therapies. The need for a cost-effective approach to purification is essential to increase yields and reach target purity levels.
YMC America has recently completed the successful co-location and expansion of its US business operations at its growing campus in Devens, Massachusetts.
YMC-Triart is a widely-utilized family of stationary phases for HPLC and Prep LC. YMC has recently developed a YMC-Triart phase ideal for peptides with aromatic residues.
Insulin is a peptide hormone. Due to the typical scale of insulin production and market pressures to increase availability and reduce the cost of insulin, there is justification to invest resources into finding improved conditions and materials for insulin purification.
Hydrophobic interaction chromatography (HIC) is often useful for antibody separations because running conditions are non-denaturing, and differences in protein surface-associated hydrophobicity offer high selectivity.
YMC's three-page Application Note highlights the practical steps of method development and scale up for the reversed-phase LC purification of the therapeutic peptide, liraglutide. The Application Note is entitled: Purification of Peptides with Full Flexibility.
PeptiDream and YMC groups announce a formal joint-task group to scale successful lab work to multiple GMP production lines for specialty peptide drug products at the main factory of PeptiStar Inc. YMC’s patented twin-column technology will be a key technology in the venture. Work is anticipated to result in the implementation of the technology on a large scale in late 2021.
Guard columns offer important functions in liquid chromatography. Guard columns protect the analytical column from contamination or damage, resulting in longer column life.
YMC's four-page Technical Note provides practical guidance for the development and improvement of methods for peptide purification. The Technical Note is entitled: How to improve a peptide purification process.
YMC plans expansion of lab development services and consolidation of its Allentown, PA, location into its larger Devens, MA, facility. The new location will facilitate an increase in customer services and a larger site staff to support the future growth of consumable products.